<?xml version="1.0"?>
<Articles JournalTitle="Basic &amp; Clinical Cancer Research">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Basic &amp; Clinical Cancer Research</JournalTitle>
      <Issn>2228-6527</Issn>
      <Volume>9</Volume>
      <Issue>2</Issue>
      <PubDate PubStatus="epublish">
        <Year>2017</Year>
        <Month>12</Month>
        <Day>25</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Endoplasmic Reticulum Stress as a Therapeutic Target in Cancer: A mini review</title>
    <FirstPage>38</FirstPage>
    <LastPage>48</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Marveh</FirstName>
        <LastName>Rahmati</LastName>
        <affiliation locale="en_US">Cancer Biology Research Center, Cancer Institute of Iran, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Saeid</FirstName>
        <LastName>Amanpour</LastName>
        <affiliation locale="en_US">Cancer Biology Research Center, Cancer Institute of Iran, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Amirhossein</FirstName>
        <LastName>Razavirad</LastName>
        <affiliation locale="en_US">Cancer Biology Research Center, Cancer Institute of Iran, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammad Amin</FirstName>
        <LastName>Moosavi</LastName>
        <affiliation locale="en_US">Department of Molecular Medicine, Institute of Medical Biotechnology, National Institute for Genetic Engineering and Biotechnology, Tehran, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2017</Year>
        <Month>09</Month>
        <Day>06</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2017</Year>
        <Month>11</Month>
        <Day>13</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Perturbation of endoplasmic reticulum (ER) homeostasis induces a stress condition described as &#x201C;ER stress&#x201D;, which in turn leads to a well-regulated program termed as unfolded protein response (UPR). The principal purpose of UPR is to reestablish the ER homeostasis. Some of the physiological and pathological situations that disrupt the homeostasis include hypoxia, glucose limitations, nutrient deprivation, low pH, genomic instability, and some cytotoxic compounds are frequently observed during the core formation and progression of tumors. These stressful microenvironments around the tumors affect the innate and adaptive immune responses. The ER stress is usually induced to activate the UPR and to handle the stress. Although the UPR mechanism is primarily a pro-survival process, preserved and/or prolonged stress may induce cell death. In tumors, ER stress may modify apoptotic and autophagic cell death and, thereby provokes drug resistance of cancerous cells to current therapies. In this mini-review, at first, we highlight the role of UPR and its mediators in cancerous cells fate and then discuss their potential opportunities in cancer therapy.</abstract>
    <web_url>https://bccr.tums.ac.ir/index.php/bccrj/article/view/252</web_url>
  </Article>
</Articles>
